2023

1. Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis

   Clinical and Translational Oncology, Vol. 25, Núm. 4, pp. 941-958

2. The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic review

   Clinical and Translational Oncology, Vol. 25, Núm. 2, pp. 417-428